Impact of dose calculation algorithm on magnetic resonance imaging-only radiotherapy for prostate and glioma
(2026) In Physics and imaging in radiation oncology 40.- Abstract
- Background and purpose: Synthetic computed tomography (sCT) enables magnetic resonance imaging (MRI)-only radiotherapy by providing electron density information for dose calculation. While sCT-based planning has been proven sufficiently accurate for convolution-based dose calculation algorithms, linear Boltzmann transport equation (LBTE)-based approaches exhibit higher sensitivity to tissue heterogeneities. This study evaluated the accuracy of both dose calculation algorithm types for MRI-only in prostate and glioma radiotherapy.
Materials and methods: Clinical treatment plans for thirty-nine prostate cancer patients and seventeen glioma patients were recalculated on atlas- and deep learning (DL)-based sCTs and conventional CT... (More) - Background and purpose: Synthetic computed tomography (sCT) enables magnetic resonance imaging (MRI)-only radiotherapy by providing electron density information for dose calculation. While sCT-based planning has been proven sufficiently accurate for convolution-based dose calculation algorithms, linear Boltzmann transport equation (LBTE)-based approaches exhibit higher sensitivity to tissue heterogeneities. This study evaluated the accuracy of both dose calculation algorithm types for MRI-only in prostate and glioma radiotherapy.
Materials and methods: Clinical treatment plans for thirty-nine prostate cancer patients and seventeen glioma patients were recalculated on atlas- and deep learning (DL)-based sCTs and conventional CT using convolution- and LBTE-based algorithms. Target dose metrics were analyzed as relative differences, while organs of interest (OOI) dose criteria were evaluated as absolute differences between sCT- and CT-based calculations. Statistical significance was assessed using paired t-tests (α = 0.05).
Results: For target volumes, statistically significant differences between sCT- and CT-based calculations were observed for both dose calculation algorithms (p < 0.001). In prostate patients, mean differences in target dose metrics were ≤ 1.4% for the LBTE-based algorithm and ≤ 0.5% for the convolution-based algorithm. Slightly smaller dose differences were observed for glioma patients, ≤ 0.8% and ≤ 0.5%, respectively. OOI dose differences were small (≤ 0.6%). The LBTE-based algorithm consistently yielded the largest dose differences between CT and sCT.
Conclusions: Although the LBTE-based approach demonstrated higher sensitivity to sCT-related CT number discrepancies than the convolution-based dose calculation algorithm, the resulting dose differences remained within clinically acceptable limits, supporting the robustness of MRI-only radiotherapy for both atlas- and DL-based sCTs. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/d0f97ac4-a75d-400b-bc41-18597153b84d
- author
- af Wetterstedt, Sacha
LU
; Persson, Emilia
LU
; Jamtheim Gustafsson, Christian
LU
; Gunnlaugsson, Adalsteinn
LU
; Lerner, Minna
LU
; Olsson, Lars E
LU
and Pommer, Tobias
LU
- organization
- publishing date
- 2026
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Physics and imaging in radiation oncology
- volume
- 40
- article number
- 101045
- publisher
- Elsevier
- external identifiers
-
- pmid:42602256
- scopus:105046544603
- ISSN
- 2405-6316
- DOI
- 10.1016/j.phro.2026.101045
- language
- English
- LU publication?
- yes
- id
- d0f97ac4-a75d-400b-bc41-18597153b84d
- date added to LUP
- 2026-09-25 13:37:36
- date last changed
- 2026-09-26 04:00:34
@article{d0f97ac4-a75d-400b-bc41-18597153b84d,
abstract = {{Background and purpose: Synthetic computed tomography (sCT) enables magnetic resonance imaging (MRI)-only radiotherapy by providing electron density information for dose calculation. While sCT-based planning has been proven sufficiently accurate for convolution-based dose calculation algorithms, linear Boltzmann transport equation (LBTE)-based approaches exhibit higher sensitivity to tissue heterogeneities. This study evaluated the accuracy of both dose calculation algorithm types for MRI-only in prostate and glioma radiotherapy.<br/><br/>Materials and methods: Clinical treatment plans for thirty-nine prostate cancer patients and seventeen glioma patients were recalculated on atlas- and deep learning (DL)-based sCTs and conventional CT using convolution- and LBTE-based algorithms. Target dose metrics were analyzed as relative differences, while organs of interest (OOI) dose criteria were evaluated as absolute differences between sCT- and CT-based calculations. Statistical significance was assessed using paired t-tests (α = 0.05).<br/><br/>Results: For target volumes, statistically significant differences between sCT- and CT-based calculations were observed for both dose calculation algorithms (p < 0.001). In prostate patients, mean differences in target dose metrics were ≤ 1.4% for the LBTE-based algorithm and ≤ 0.5% for the convolution-based algorithm. Slightly smaller dose differences were observed for glioma patients, ≤ 0.8% and ≤ 0.5%, respectively. OOI dose differences were small (≤ 0.6%). The LBTE-based algorithm consistently yielded the largest dose differences between CT and sCT.<br/><br/>Conclusions: Although the LBTE-based approach demonstrated higher sensitivity to sCT-related CT number discrepancies than the convolution-based dose calculation algorithm, the resulting dose differences remained within clinically acceptable limits, supporting the robustness of MRI-only radiotherapy for both atlas- and DL-based sCTs.}},
author = {{af Wetterstedt, Sacha and Persson, Emilia and Jamtheim Gustafsson, Christian and Gunnlaugsson, Adalsteinn and Lerner, Minna and Olsson, Lars E and Pommer, Tobias}},
issn = {{2405-6316}},
language = {{eng}},
publisher = {{Elsevier}},
series = {{Physics and imaging in radiation oncology}},
title = {{Impact of dose calculation algorithm on magnetic resonance imaging-only radiotherapy for prostate and glioma}},
url = {{http://dx.doi.org/10.1016/j.phro.2026.101045}},
doi = {{10.1016/j.phro.2026.101045}},
volume = {{40}},
year = {{2026}},
}